By Lillie Mermoud Ashlynn Jones is a true champion. At 11 years old, she has overcome  incredible challenges in her life, including a diagnosis of CHAMP1 disorder. Patients with this rare genetic disorder are lovingly called “CHAMP1ONS”, and she truly embodies the name. Ashlynn is a champion for children facing adversity, especially those navigating the […]

Reagan was diagnosed with autism spectrum disorder when she was 18 months old, a diagnosis that never sat quite right with Reagan’s mother, Kristi, who was a nurse at the time. Kristi knew there were more complexities to what Reagan faced but did not realize until much later that genetic testing could be the key to learning more about her daughter.

Genetic testing can shed light on undiagnosed rare diseases that may not be found otherwise, offering medically actionable results that can help physicians inform and adapt a patient’s care plan.

As genetic testing has become more accessible and scientists begin to better understand how Alzheimer’s disease develops, genetic testing to learn your risk for Alzheimer’s disease has become increasingly popular.

DNA is the blueprint for our bodies’ development and function, providing instructions for everything from eye color to how our bodies fight disease.

Until recently, the idea of unlocking the secrets of our genes through genetic testing seemed like something out of a science fiction novel or something reserved for the wealthy elite.

How a partnership between the Alabama Children’s Rehabilitation Service (CRS) and HudsonAlpha’s Smith Family Clinic for Genomic Medicine changed a little girl’s life through a globally significant diagnosis

Over 95% of people have a genetic change that affects how they respond to common medications, making some drugs more or less effective for each person. Some medications that are known to be impacted by genetics are statins, pain killers, blood pressure medications, antidepressants, blood thinners, chemotherapy drugs, and many more.